Fibrosis, Liver
Information
- Disease name
- Fibrosis, Liver
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03158818 | Active, not recruiting | Chronic Hepatitis B Virus Infection in Zambia | August 23, 2016 | August 2024 | |
| NCT05479721 | Active, not recruiting | LITMUS Imaging Study | September 4, 2019 | October 31, 2024 | |
| NCT05402371 | Active, not recruiting | Phase 2 | A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis | October 15, 2022 | September 2025 |
| NCT06315361 | Active, not recruiting | DIAbetes and NAFLD | May 20, 2019 | December 31, 2035 | |
| NCT04595474 | Active, not recruiting | Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes | January 14, 2021 | December 30, 2024 | |
| NCT05473806 | Active, not recruiting | Phase 4 | Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes | September 18, 2020 | February 19, 2023 |
| NCT02344680 | Active, not recruiting | Liver Fibrosis in Zambian HIV-HBV Co-infected Patients | October 2015 | August 2024 | |
| NCT04480710 | Completed | Phase 2 | A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects | June 23, 2020 | October 30, 2021 |
| NCT04493346 | Completed | Shear Wave Elastography | May 21, 2018 | April 11, 2022 | |
| NCT00006164 | Completed | Phase 3 | Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment | June 2000 | October 2009 |
| NCT02682108 | Completed | N/A | Diffusion-weighted Imaging Magnetic Resonance for Assessing Liver Fibrosis | April 2014 | June 2016 |
| NCT03373396 | Completed | N/A | Impact of Chlordecone on Active Chronic Hepatitis | November 8, 2011 | December 21, 2015 |
| NCT03548597 | Completed | Evaluation of the Diagnostic of Hepatic Fibrosis With the in Severe Obese Patients Candidates to Bariatric Surgery | April 4, 2012 | December 6, 2016 | |
| NCT03656068 | Completed | Phase 2 | An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis | December 4, 2018 | November 25, 2020 |
| NCT03659058 | Completed | N/A | Impact of Ursodeoxycholic Acid, Silymarin, Antioxidants and Colchicine on Fibrosis Regression in HCV After SVR | March 2, 2016 | August 1, 2018 |
| NCT04380493 | Completed | The Use of the Transient Elastography Paediatric Probe, Compared to the M Probe, Indirect Biomarkers and Histology | May 2015 | December 2019 | |
| NCT04759521 | Completed | Evaluation of Liver Fibrosis With 2D-Shear Wave Elastography | January 3, 2019 | December 18, 2020 | |
| NCT06463223 | Not yet recruiting | HIBOC = Hepatic Imaging Biomarkers in Obese Children | October 2024 | December 2029 | |
| NCT06366425 | Not yet recruiting | N/A | Screening for Chronic Liver Diseases in General Population | May 1, 2024 | March 2025 |
| NCT05651724 | Not yet recruiting | Global Research Initiative for Patients Screening on NASH | January 1, 2023 | March 31, 2031 | |
| NCT05567614 | Not yet recruiting | Platelets Indices and Its Role to Predict Liver Fibrosis in Patients With Chronic Hepatitis B Infection | October 20, 2022 | December 15, 2023 | |
| NCT04442334 | Recruiting | The European NAFLD Registry | May 1, 2015 | December 31, 2030 | |
| NCT04620538 | Recruiting | Volatile Organic Compounds for the Assessment of Liver Disease | April 1, 2021 | September 2025 | |
| NCT05147090 | Recruiting | Phase 4 | Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B | January 2, 2022 | December 31, 2025 |
| NCT05196867 | Recruiting | N/A | Liver Cancer Prevention Randomized Control Trial | February 11, 2022 | August 30, 2025 |
| NCT05692024 | Recruiting | Phase 1/Phase 2 | COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER | March 21, 2024 | December 1, 2027 |
| NCT05855031 | Recruiting | N/A | The Liver Care Trial | May 8, 2023 | May 1, 2027 |
| NCT06005012 | Recruiting | Phase 2 | Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM | July 25, 2023 | June 2025 |
| NCT06111859 | Recruiting | N/A | Effectiveness of Ultrasound in Liver Stiffness and Fat Quantification | January 2, 2023 | July 2, 2025 |
| NCT06248580 | Recruiting | Find HDV and Determine Its Status in Turkey | March 11, 2024 | March 1, 2025 | |
| NCT06293378 | Recruiting | N/A | Safety and Effectiveness of Sulfasalazine in the Treatment of Liver Fibrosis/Cirrhosis. | February 1, 2024 | October 10, 2028 |
| NCT04175392 | Terminated | Phase 1/Phase 2 | Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis | January 12, 2021 | March 1, 2022 |
| NCT03492879 | Unknown status | N/A | Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases Severity | May 15, 2018 | May 30, 2019 |
| NCT03222167 | Unknown status | Phase 3 | Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b | October 2017 | August 2019 |
| NCT04493762 | Unknown status | Liver Fibrosis and Gut Microbiota in Patients With Psoriasis Vulgaris and Rheumatoid Arthritis on Methotrexate | August 13, 2020 | December 11, 2022 | |
| NCT05218538 | Unknown status | Liver Cirrhosis Diagnosis Prioritizing Algorithm Based on Electronic Health Records. | March 15, 2022 | December 2023 | |
| NCT02569567 | Unknown status | Comparison of Smart-Shear Wave Elastography and Transient Elastography | November 2015 | June 2016 | |
| NCT05120557 | Unknown status | N/A | Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH | September 2022 | September 2023 |